HCA Healthcare, Inc. financial data

Symbol
HCA on NYSE
Location
One Park Plz, Nashville, TN
Fiscal year end
December 31
Former names
HCA Holdings, Inc. (to 5/5/2017), HCA INC/TN (to 11/24/2010), HCA THE HEALTHCARE CO (to 5/21/2001), HCA-THE HEALTHCARE CO (to 2/14/2001), COLUMBIA HCA HEALTHCARE CORP (to 5/19/2000), COLUMBIA HCA HEALTHCARE CORP/ (to 2/16/2000), COLUMBIA HEALTHCARE CORP (to 3/1/1994)
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 113 % -8.55%
Quick Ratio 13.6 % -25.7%
Return On Equity 532 % -77.3%
Return On Assets 10.3 % -3.83%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 253M shares -5.37%
Common Stock, Shares, Outstanding 255M shares -5.37%
Entity Public Float 61.1B USD +69%
Weighted Average Number of Shares Outstanding, Basic 257M shares -5.31%
Weighted Average Number of Shares Outstanding, Diluted 260M shares -5.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 69.6B USD +10.2%
General and Administrative Expense 359M USD +10.8%
Costs and Expenses 60.9B USD +11.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 8.74B USD +0.83%
Income Tax Expense (Benefit) 1.9B USD +6.49%
Net Income (Loss) Attributable to Parent 5.93B USD +3.73%
Earnings Per Share, Basic 22.6 USD/shares +9.73%
Earnings Per Share, Diluted 22.3 USD/shares +9.93%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.89B USD +224%
Accounts Receivable, after Allowance for Credit Loss, Current 9.92B USD +7.98%
Inventory, Net 1.78B USD -12.5%
Other Assets, Current 2.08B USD -4.93%
Assets, Current 16.7B USD +16.6%
Property, Plant and Equipment, Net 29B USD +7.12%
Operating Lease, Right-of-Use Asset 2.2B USD +5.87%
Other Assets, Noncurrent 309M USD +54.5%
Assets 59.5B USD +8.92%
Accounts Payable, Current 4.24B USD +2.32%
Liabilities, Current 14.9B USD +20.1%
Operating Lease, Liability, Noncurrent 1.92B USD +8.33%
Accumulated Other Comprehensive Income (Loss), Net of Tax -378M USD +23%
Retained Earnings (Accumulated Deficit) -1.81B USD +9.15%
Stockholders' Equity Attributable to Parent -2.18B USD +11.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 786M USD +120%
Liabilities and Equity 59.5B USD +8.92%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.47B USD +36.9%
Net Cash Provided by (Used in) Financing Activities -1.22B USD -67.7%
Net Cash Provided by (Used in) Investing Activities -903M USD +21.5%
Common Stock, Shares Authorized 1.8B shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 349M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.89B USD +224%
Interest Paid, Excluding Capitalized Interest, Operating Activities 538M USD -6.27%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.25 pure 0%
Operating Lease, Liability 2.27B USD +7.09%
Payments to Acquire Property, Plant, and Equipment 1.12B USD -6.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6.04B USD +3.87%
Lessee, Operating Lease, Liability, to be Paid 3.24B USD +17.9%
Property, Plant and Equipment, Gross 61.8B USD +6.89%
Operating Lease, Liability, Current 363M USD -0.28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 394M USD +3.68%
Lessee, Operating Lease, Liability, to be Paid, Year One 452M USD +3.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +22.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 976M USD +54.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 340M USD +6.25%
Unrecognized Tax Benefits 639M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 288M USD +7.06%
Depreciation, Depletion and Amortization 3.25B USD +6.81%
Deferred Tax Assets, Net of Valuation Allowance 2.22B USD +1.56%
Interest Expense 2.02B USD +6.53%